PEOPLE - Cholestech (US) makes appointment:
This article was originally published in Clinica
Jeffrey Aroy has joined US diagnostic screening company Cholestech as corporate vice president with responsibility as Chief operating officer for the Wellcheck.com business unit. He joins from IBM. Timothy Still is promoted to vice-president of Cholestech's diagnostic products business unit.
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.